Wave 2 – Archetypes
Compelling Primary Use Cases to Speed through Wave 2 and Develop an MVP
1) Startups building optimized infrastructure to extract value from emerging and maturing data sources
Companies are using novel data sources (e.g. biosensors, miniaturized sensors, LIDAR), and applying them to augment system performance.
2) There is an explosion in data but solutions that ensure reliability are needed
Teams tackling use cases where consistently-labeled training data does not exist or introduces unwanted effects, like bias, drift, lack of interpretability, and low predictive power are compelling.
3) Companies balancing off-the-shelf and custom built solutions, innovating in speed to implementation
In this approach, companies abstract the hardware into software objects, and continually expand capabilities via software updates while the hardware remains (mostly) unchanged. Off-the-shelf equipment is great for W2 demonstration, early validation and initial adoption, while circling back to custom built enables W3 performance improvements and platform capabilities.
4) Startups creating breakthroughs in scaling existing platforms or services
Containers, popularized by Docker, helped scale software services in the cloud. However, container management was cumbersome and unreliable, until Kubernetes bridged that gap.
5) Biology teams transcending science to harness computer science via DNA synthesis, lab automation, and machine learning
These teams are focused on designing bio-products to solve unique requirements like sustainability, taste or low unit cost. Companies in this space are typically focused on engineering a bio-process based on an already-proven scientific breakthrough, and are pushing the limits of engineering to get to market.
Adoption cycles in hardware are long and building for interoperability is capital and time intensive. This slows down go-to-market velocity for startups in hardware or component-focused businesses like System-on-Chip (SoC), networking devices or battery makers. For this reason, we shy away from these plays as part of our investment thesis.
Last updated